The (Cost)Effect of Smart Diaper Continence Care for People With Profound Intellectual and Multiple Disabilities

Summary

Background and study aims

Most people with profound intellectual and multiple disabilities (PIMD) use diapers. When living in a long-term care facilities, most changes of diapers are scheduled. Leading to leakages, unnecessary changes and burden to people with PIMD and their caregivers.

With the use of continence material with sensor (smart diapers) caregivers give more client-based continence care. The smart diaper (product name: Abena Nova) informs the caregivers about the saturation level of the diaper and gives a notification when change is needed or a leakage might occur. This can result in less leakages compared to regular continence care. And we will research the effect on quality of life and number of pad changes and cost effectiveness. The study also investigates the effect on the care givers.

Who can participate?

People with profound intellectual and multiple disabilities, of 18 years and older, who use diapers and live in one of the participating disability care organizations.

What does the study involve?

To investigate the effect, the disability care organization will be assigned to one of the two groups. In one group we will research the use of the smart diaper, the other group will continue their regular continence care.

Data collection started September 2021 and will continue roughly till February 2023. Research period for each location is 12 weeks, with 3 points for data collection. For the first two organization who are using the smart diaper, there is also data collection after 9 months.

Caregivers will fill out questionnaires about the quality of life, received healthcare of the participant, and keep a one week diary about the diaper changes and leakages.

To use the smart diaper, caregivers will receive training, there are meetings to optimize usage and the disability care organization will receive help from the researchers.

Possible benefits and risk of participating?

The potential benefit of participating lays within the organization itself, optimizing continence care and investigating whether this is cost effective. Any negative effect is the cost of the product and the additional time and effort it takes to start using smart diapers. For the patients the benefit is getting more optimized continence care. Any potential discomfort or risk (such as removing of swallowing the sensor) will be evaluated before the start. Any negative advice will result in not implementing the smart diaper for this person showing risk behavior. However, any of these adverse events cannot be complete diminished.

Where does the study run from?

Study is run by Academy Het Dorp, one of the researcher is also affiliated with Tranzo, Tilburg University

Who is funding the study?

ZonMW is funding the research activities. Disability care organization are themselves paying for the smart diapers.

Who is the main contact?

Vivette van Cooten, MSc [email protected]

Conditions

• Incontinence

Interventions

DEVICE

Continence material with sensor

Healthcare organizations are prepared for the use of smart continence care (for the intervention condition) using specially developed implementation guideline. They receive training, including how to apply continence material (only provided to intervention condition). Each participating location will use the product for 12 weeks. Correct size and absorption level will be determined for each participant. The optimize the result, this can change. Evaluation meetings with the caregivers, supplier and researcher will be held. Resulting in suggestions for alterations in continence care provided or products used, or giving indications that a team needs support in any way to foster the implementation. After 12 weeks, the implementation guidance from the research group will be phased out. The waiting list group will continue their continence care as usual during data collection period. Thereafter they will receive support for implementing smart continence care.

Sponsors & Collaborators

• Tilburg University

  collaborator OTHER

• Stichting Trimbos-Instituut

  collaborator OTHER

• Maastricht University

  collaborator OTHER

• s Heeren Loo Zorggroep

  collaborator UNKNOWN

• Esdégé-Reigersdaal

  collaborator UNKNOWN

• Lunet

  collaborator UNKNOWN

• Siza

  collaborator UNKNOWN

• Zozijn

  collaborator UNKNOWN

• Academy Het Dorp

  lead OTHER

Principal Investigators

• Brigitte Boon, Prof. Dr. · Academy Het Dorp, Arnhem, The Netherlands

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-07-28

Primary Completion

2023-02-28

Completion

2023-02-28

Countries

• Netherlands

Study Locations